Darbepoetin alfa (40mcg)
Darbelife 40mcg Pfs Injection is a medicine that needs to be used with utmost care because it can lead to serious side effects. It is important that you seek treatment from a doctor who is experienced in providing this medical therapy. You should follow all the directions of the doctor strictly. It is given under the supervision of a healthcare professional.Common side effects include abdominal pain, high blood pressure, rash, injection site pain, breathlessness, cough, and peripheral edema. Inform your doctor if there are symptoms of very high blood pressure such as severe headache, problems with your eyesight, nausea, vomiting, or fits (seizures).Your doctor may get your blood tests done regularly to monitor the levels of salts (electrolytes such as potassium), hemoglobin, and blood cells in your blood. You should stop taking it and consult with a doctor if you develop shortness of breath or skin rash.Before taking Darbelife 40mcg Pfs Injection, tell your doctor if you have heart disease, high blood pressure, or have had a seizure or stroke. If you are pregnant or breastfeeding, or plan to become pregnant or breastfeed, consult your doctor to make sure it is safe for you.
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about themCommon side effects of Darbelife
1 Injection
Hetero Drugs Ltd
Image shown is a representation and may slightly vary from the actual product. Every effort is made to maintain accuracy of all information displayed.
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Darbelife 40mcg Pfs Injection is an erythropoiesis-stimulating agent (ESA). It works by stimulating the bone marrow (soft tissue inside the bones which produces red blood cells) to produce more red blood cells.
Related Warnings
It is not known whether it is safe to consume alcohol with Darbelife 40mcg Pfs Injection. Please consult your doctor.
Darbelife 40mcg Pfs Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Darbelife 40mcg Pfs Injection is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Darbelife 40mcg Pfs Injection does not usually affect your ability to drive.
Darbelife 40mcg Pfs Injection is safe to use in patients with kidney disease. No dose adjustment of Darbelife 40mcg Pfs Injection is recommended.
Darbelife 40mcg Pfs Injection should be used with caution in patients with liver disease. Dose adjustment of Darbelife 40mcg Pfs Injection may be needed. Please consult your doctor.
You will be able to notice an increase in the count of red blood cells (hemoglobin levels) in 2-6 weeks of starting Darbelife 40mcg Pfs Injection. If you have any other concerns, consult your doctor.
Darbelife 40mcg Pfs Injection is a medicine that needs to be used with utmost care because it can lead to serious side effects and even death of the patient. It is important that you seek treatment from a doctor who is experienced in providing Darbelife 40mcg Pfs Injection therapy. Follow all the directions strictly.
You may not respond to Darbelife 40mcg Pfs Injection if you have deficiencies of iron, folic acid or vitamin B12. It is important that you take measures to correct these deficiencies. Other reasons behind not responding to the treatment could be bleeding, infections, inflammation and bone marrow fibrosis. Therefore, consult our doctor regarding the same.
Yes, Darbelife 40mcg Pfs Injection is used to treat anemia due to chronic kidney disease in children who are above 1 year of age. The effectiveness of Darbelife 40mcg Pfs Injection and side effects seen in children are similar to adults. However, consult your doctor if you are not sure.
Yes, Darbelife 40mcg Pfs Injection can affect blood pressure. During initial therapy with Darbelife 40mcg Pfs Injection, blood pressure should be monitored and those who have high blood pressure should take appropriate measures to control blood pressure. Your doctor may stop Darbelife 40mcg Pfs Injection if the blood pressure remains uncontrolled.
Individuals who have cancer but have not been prescribed Darbelife 40mcg Pfs Injection by the doctor should not take it. Additionally, patients with uncontrolled hypertension (high blood pressure), patients with a history of anemia called pure red cell aplasia (PRCA) that starts after treatment with Darbelife 40mcg Pfs Injection or other erythropoietin medicines, and patients with a history of serious allergic reaction to this medicine should not take this medicine.
